• Facebook App Icon
  • Twitter App Icon
  • Google+ App Icon

Murray IR, Geeslin AG, Goudie EB, Petrigliano FA, LaPrade RF.  Minimum Information for Studies Reporting Biologics in Orthopaedics (MIBO):  Platelet Rich Plasma and Mesenchymal Stem Cells.  J Bone Joint Surg Am 2017;99:809-19.

 

Murray IR, LaPrade RF. Platelet Rich Plasma: renewed scientific understanding must guide appropriate use. Bone Joint Research 2016;5(3):92-4. 

 

LaPrade RF, Dragoo JL, Koh JL, Murray IR, Geeslin AG, Chu CR. AAOS Research Symposium Updates and Consensus: Biologic Treatment of Orthopaedic Injuries. J Am Acad Orthop Surg 2016;24(7):e62-78. 

 

LaPrade RF, Geeslin AG, Murray IR, Musahl V, Zlotnicki JP, Petrigliano FP, Mann B. Biologic Treatments for Sports Injuries II Think Tank Updates: Identification of Barriers to the Use of Biologics to Treat Ligament, Tendon, Articular Cartilage, and Rotator Cuff Pathology. Am J Sports Med 2016;44(12):3270-3283

 

Murray IR, LaPrade RF, Geeslin AG, Musahl V, Zlotnicki JP, Mann B, Petrigliano FP. Biologics for rotator cuff regeneration: Current concepts, barriers to advancement and future research. Orthopaedic Journal of Sports Medicine 2016;31;4(3):2325967116636586. 

 

Zlotnicki JP, Geeslin AG, Murray IR, Petrigliano FP, Mann B, LaPrade RF, Musahl V. Biologic therapies for the treatment of cartilage defect: Current and emerging therapies, the role of advanced imaging and barriers to advancement. Orthopaedic Journal of Sports Medicine 2016;4(4):2325967116642433 

‚Äč

KEY REFERENCES